Pathogenetic, Diagnostic and Therapeutic Perspectives in Head and Neck Cancer
Topic Information
Dear Colleagues,
Head and neck cancers constitute the sixth most common malignancy in the world. The overall 5-year survival for head and neck cancers is approximately 50%; this statistic has not changed much in the past few decades. Despite current advances in surgery and other treatment options, the fatality of head and neck cancers has remained mostly unchanged in years. This Special Issue welcomes research articles and review papers focused on pathogenetic, diagnostic, and therapeutic perspectives in head and neck cancer, from basic translational science studies to clinical research. We are pleased to invite you to our Special Issue on “Pathogenetic, Diagnostic, and Therapeutic Perspectives in Head and Neck Cancer”. We look forward to receiving your contributions.
Prof. Dr. Shun-Fa Yang
Dr. Ming-Hsien Chien
Topic Editors
Keywords
- head and neck cancer
- oral cancer
- biomarkers
- therapeutic target
- genetic aberrations
- molecular pathology